If You Have Been Off of Statins for a Year Can You Start Taking Them Again
Story highlights
- New written report: Those who stop taking statins due to side effects accept higher rates of middle attacks, strokes and decease from any cause
- Most people have no side effects, merely some experience muscle pains, cerebral issues and other problems
(CNN)Jonathan McDonagh, a 57-year-erstwhile computer consultant in Minneapolis, Minnesota, gave up on statins years ago.
He was having trouble remembering people's names. His productivity at work was dropping. But he didn't think that a medicine for his heart health could exist fogging up his encephalon.
"I found myself slowly sinking into a ocean of troubles," McDonagh wrote in a medical journal in 2014, offering his perspective every bit a patient. "I didn't connect my issues with the statin."
Statins are a grouping of cholesterol-lowering drug meant to lower your risk of heart set on and stroke. Over a quarter of Americans over historic period 40 have them, according to the United states Centers for Affliction Control and Prevention.
Research has linked the drugs with a number of side effects, such every bit musculus pain, increased blood saccharide and memory problems. But the bulk of patients accept no side effects at all.
Days after running out of pills and forgetting to refill his prescription, McDonagh felt unlike. He was more aware of his peripheral vision and could change lanes on the freeway without feeling nervous.
"It was pretty dramatic," McDonagh told CNN.
So he decided to stop taking the medication altogether. Now a new report, published Monday, follows how patients like him fare after going off these drugs.
Researchers studied over 28,000 patients in Massachusetts and establish iii in ten stopped taking statins after experiencing side effects, which were presumed to exist due to the drugs. Some 8.v% of them had a cardiovascular event, such as a heart attack or stroke, within iv years -- versus seven.vi% of those who continued taking statins.
And six.6% of patients who stopped taking statins died of all causes, versus 5.4% of those who kept taking them. The researchers did not accept information on what the causes of decease were.
Taken together, that's a i.7% divergence in these negative outcomes, the researchers noted.
"That's a very significant number," said Cleveland Clinic cardiologist Dr. Steven Nissen, who was not involved in the report but penned an accompanying editorial in the aforementioned journal. "Those kinds of numbers are typically what nosotros see for very effective therapies."
In other words, 59 of these patients would demand to proceed taking statins for four years to forestall one case of centre assault, stroke or death, Nissen said.
Nissen, who has spoken out against statin guidelines in the past, has researched statin alternatives that led to an approval by the US Nutrient and Drug Clan. He said he receives enquiry grants, only not personal funds, from pharmaceutical companies.
Dr. Alexander Turchin, an writer of the new study and an acquaintance professor of medicine at Harvard Medical School, wasn't surprised past his findings. He said the research brutal in line with what we already knew most the benefits of statins.
Turchin too receives grants from pharmaceutical companies, but those grants did non fund this new inquiry.
1 practiced questioned whether his findings had much to do with statins at all.
"We don't know what (else) was different almost the groups," said Dr. Rita Redberg, a professor of medicine at University of California, San Francisco. Redberg was not involved in Turchin's research. "People that take medicines and are adherent exercise better than people that don't."
For case, those who take medications consistently might too eat better or exercise more than, Redberg added. Then a "small deviation" between the groups "isn't that revealing," she said.
Redberg as well noted that the report did not split patients who had already had a heart attack or stroke. She said that there is plenty of good evidence to recommend statins to patients who have had cardiovascular problems, but that in that location is "footling to no benefit" in using statins to forbid a cardiac event in those who haven't had one before. The latter remains a topic of fence.
Experts say that McDonagh'south experience every bit a patient is uncommon, but exactly how uncommon is unclear. It is difficult to know whether a reported symptom is truly caused by statins, and many studies do not ask patients near mutual side furnishings, co-ordinate to experts.
Roughly one in five patients on statins experienced a side effect, the new study establish. This is higher than other studies have estimated, but it could have to exercise with the way the written report was designed, Turchin said.
Nissen said that statins have developed a "bad reputation with the public," largely due to websites that peddle scary and unscientific claims about statins.
"We have a large number of people in the public that have been convinced by this internet cult that statins are bad for you," said Nissen, who compared the trend to discussions surrounding vaccines and climate change. "How did nosotros become into this kind of a mess?"
These claims, Nissen said, could really increment reported side furnishings. The more patients are aware -- and perhaps fearful -- of statins and their side effects, the more probable they are to report those side effects. This miracle is known every bit the "nocebo consequence," the opposite of the placebo upshot.
Heavy media coverage of statins may too lead people to stop taking them, according to a study from the UK. Withal, this effect disappeared after six months.
"It's our homo nature that we are interested in negative news much more than nosotros're interested in positive news," said study author Turchin, likewise a practicing endocrinologist at Brigham and Women's Hospital.
McDonagh is no stranger to confusion over these medications. When he finally connected the dots betwixt his medications and his symptoms, he found other people talking most the same thing online. He said patients may get mixed messages from optimistic doctors, the skeptical internet and even drug commercials, whose fast-talking voiceovers list off side furnishings.
"You've got a very short menses of time with the doctors," he told CNN. "The onus is sometimes on the patients to check these things."
When patients come to Turchin with side effects, he said they weigh the risks for centre attack and stroke, the severity of their symptoms and how likely information technology is that those symptoms are due to the statin itself. Some patients may try a unlike statin.
Of the patients who continued taking statins in the new study, nearly two in five changed to a different statin. About a quarter of them reported a side outcome on the new statin.
"It remains a judgment call," Turchin said. "At that place'south non a perfect algorithm."
Realizing that statins wouldn't work for him, McDonagh constitute the motivation he needed to lose weight. He lost roughly 45 pounds and has kept almost of it off. While he acknowledged that statins can be a big benefit to some, he stands by his decision.
"I've got no regrets right now," said McDonagh. "I haven't had a heart assail."
He quickly added, "If something were to happen, mayhap I'd feel different."
Source: https://www.cnn.com/2017/07/24/health/statins-side-effects-outcomes-study/index.html
0 Response to "If You Have Been Off of Statins for a Year Can You Start Taking Them Again"
Post a Comment